Biglari Holdings Inc  

(Public, NYSE:BH)   Watch this stock  
Find more results for BIGLARI HOLDINGS, INC
392.96
-0.82 (-0.21%)
Apr 28 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 390.00 - 396.27
52 week 312.00 - 457.99
Open 392.05
Vol / Avg. 1,801.00/7,171.00
Mkt cap 811.24M
P/E 7.06
Div/yield     -
EPS 55.65
Shares 2.07M
Beta 1.07
Inst. own 78%
Mar 13, 2015
Full Year 2014 Biglari Holdings Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 40.57% -
Operating margin 3.00% -
EBITD margin - -
Return on average assets 27.24% -
Return on average equity 49.71% -
Employees 23,851 -
CDP Score - -

Address

17802 W Interstate 10 Ste 400
SAN ANTONIO, TX 78257-2509
United States - Map
+1-210-3443400 (Phone)
+1-210-3443411 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Biglari Holdings Inc. (Biglari Holdings) is a holding company. The Company is engaged in a number of business activities. The Company, along with its subsidiaries, is engaged in investment management and the franchising/operating of restaurants. The Company�s restaurant operations activities are conducted through two restaurant concepts, Steak n Shake and Western Sizzlin. As of September 24, 2014, Steak n Shake operated 416 company-operated restaurants and 124 franchised units. Western operated 4 company-operated restaurants and 71 franchised units.

Officers and directors

Sardar Biglari Chairman of the Board, Chief Executive Officer
Age: 37
Bio & Compensation  - Reuters
Philip L. Cooley Ph.D. Vice Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Bruce Lewis Controller
Age: 49
Bio & Compensation  - Reuters
Kenneth R. Cooper Independent Director
Age: 70
Bio & Compensation  - Reuters
William L. Johnson Lead Independent Director
Age: 72
Bio & Compensation  - Reuters
James P. Mastrian Independent Director
Age: 72
Bio & Compensation  - Reuters
Ruth J. Person Independent Director
Age: 69
Bio & Compensation  - Reuters